Table 3. Chemotherapy agents and trials.
Included in the NCCN Guidelines Version 1.2018 Uterine Sarcoma as other options (combination and single agent) [102].
Included in the NCCN Guidelines Version 1.2018 Uterine Sarcoma as preferred therapies.
Abbreviations: —, no data; LMS, leiomyosarcoma; N/A, not applicable; NCCN, National Comprehensive Cancer Network; OS, overall survival; PFS, progression‐free survival; STS, soft‐tissue sarcoma; uLMS, uterine leiomyosarcoma.